Arturo Loaiza-Bonilla on Clubhouse

Bio

Arturo Loaiza-Bonilla, MD, MSEd, is the Enterprise Vice Chief of Medical Oncology and the Enterprise Medical Director of Research at CTCA, as well as the Senior Medical Director at Vidence. An internationally renowned medical oncologist and researcher, Dr. Bonilla has a distinguished academic and clinical career in precision medicine oncology, immunotherapy, clinical trial design, use of AI in oncology, digital health, and patient advocacy.

Prior to joining CTCA, Dr. Bonilla co-founded Massive Bio (www.massivebio.com), a global industry leader in connecting patients to clinical trials, and continues to serve as Chief Medical Advisor.

Today, Dr. Bonilla holds numerous leadership positions such as President of the Pennsylvania Society of Oncology and Hematology and President of the Board of Directors of the Global Alliance for Patient Access. In 2018, he was recognized as Philadelphia Business Journal’s Forty Under 40, and in 2019 he was bestowed the 2019 Influencers of Healthcare Award – Outstanding Healthcare Provider award by the Philadelphia Inquirer. He was also selected in Castle Connolly's and Philadelphia Magazine's Top Doctors listing since 2018.

Entrepreneur – Innovation – Clinical trials – Artificial intelligence – Cancer genomics and Biomarkers – Big data – Medical education – Technology – Blockchain – Digital health – Value based care – Personalized medicine – Hematology – Telehealth – Neural networks – Virtual tumor boards – Pharmacoeconomics – IoT – Global health